News on Achillion Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated Achillion Pharmaceuticals news from BioPortfolio.com Tue, 09 Feb 2010 21:22:42 GMT en Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037712&HITNO=0&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037712&THISHREF=http://c.moreover.com/click/here.pl%3fz2537245827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037712&HITNO=0&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037712&THISHREF=http://c.moreover.com/click/here.pl%3fz2537245827%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ProQuest Investments III, L.P.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037324&HITNO=1&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037324&THISHREF=http://c.moreover.com/click/here.pl%3fz2537027596%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037324&HITNO=1&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037324&THISHREF=http://c.moreover.com/click/here.pl%3fz2537027596%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Achillion Pharmaceuticals raises $24.58 million through public offering of common stockhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022814&HITNO=2&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022814&THISHREF=http://c.moreover.com/click/here.pl%3fz2527870570%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022814&HITNO=2&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022814&THISHREF=http://c.moreover.com/click/here.pl%3fz2527870570%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Achillion licences Elvucitabine development in China to GCAThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020285&HITNO=3&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020285&THISHREF=http://c.moreover.com/click/here.pl%3fz2526691020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020285&HITNO=3&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020285&THISHREF=http://c.moreover.com/click/here.pl%3fz2526691020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Achillion Pharmaceuticals raises $24.58 million through public of...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022734&HITNO=4&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022734&THISHREF=http://c.moreover.com/click/here.pl%3fz2527836091%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022734&HITNO=4&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022734&THISHREF=http://c.moreover.com/click/here.pl%3fz2527836091%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Achillion Pharmaceuticals raises $24.58 million through public offering of common stockhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022680&HITNO=5&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022680&THISHREF=http://c.moreover.com/click/here.pl%3fz2527795640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022680&HITNO=5&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022680&THISHREF=http://c.moreover.com/click/here.pl%3fz2527795640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ATLAS VENTURE FUND V LPhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022752&HITNO=6&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022752&THISHREF=http://c.moreover.com/click/here.pl%3fz2527845501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022752&HITNO=6&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022752&THISHREF=http://c.moreover.com/click/here.pl%3fz2527845501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Achillion collects $24.6M from stock offeringhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010684&HITNO=7&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010684&THISHREF=http://c.moreover.com/click/here.pl%3fz2522570497%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010684&HITNO=7&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010684&THISHREF=http://c.moreover.com/click/here.pl%3fz2522570497%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHartford Business Journal: Achillion Pharma Out-Licensed China Rights for HIV, Hepatitis Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013167&HITNO=8&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013167&THISHREF=http://c.moreover.com/click/here.pl%3fz2523635964%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013167&HITNO=8&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013167&THISHREF=http://c.moreover.com/click/here.pl%3fz2523635964%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: Ann Taylor, Lexmark, Achillion Pharma big movershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013380&HITNO=9&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013380&THISHREF=http://c.moreover.com/click/here.pl%3fz2523707387%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013380&HITNO=9&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013380&THISHREF=http://c.moreover.com/click/here.pl%3fz2523707387%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWRIC TV: Achillion Pharmaceuticals Inc-Therapeutic Competitors - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008519&HITNO=10&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008519&THISHREF=http://c.moreover.com/click/here.pl%3fz2521566090%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008519&HITNO=10&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008519&THISHREF=http://c.moreover.com/click/here.pl%3fz2521566090%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Top Biotechnology Stocks Gainers (NASDAQ: CYCC, ACHN, PARD)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004416&HITNO=11&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004416&THISHREF=http://c.moreover.com/click/here.pl%3fz2519945231%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004416&HITNO=11&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004416&THISHREF=http://c.moreover.com/click/here.pl%3fz2519945231%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Achillion Announces Closing of Underwriters' Over-Allotment Optionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005268&HITNO=12&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005268&THISHREF=http://c.moreover.com/click/here.pl%3fz2520302636%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005268&HITNO=12&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005268&THISHREF=http://c.moreover.com/click/here.pl%3fz2520302636%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ann Taylor, Lexmark, Achillion Pharmaceuticals, Alcoa are among market movers Tuesdayhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004591&HITNO=13&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004591&THISHREF=http://c.moreover.com/click/here.pl%3fz2520038028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004591&HITNO=13&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004591&THISHREF=http://c.moreover.com/click/here.pl%3fz2520038028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNW32.com: Achillion Pharmaceuticals, Inc.-Deals & Alliances Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003464&HITNO=14&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003464&THISHREF=http://c.moreover.com/click/here.pl%3fz2519513056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003464&HITNO=14&MSIZE=157&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Achillion%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003464&THISHREF=http://c.moreover.com/click/here.pl%3fz2519513056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: